Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients

Background Acromegaly is associated with an increased risk of fatal and non-fatal cardiovascular (CV) events. Controlling acromegaly decreases, but does not normalize this risk. Brain natriuretic peptide (BNP) assessment is used in the general population for the diagnosis of heart failure and to pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragonese, Marta, Di Bella, Gianluca, Spagnolo, Federica, Grasso, Loredana, Alibrandi, Angela, Giuffrida, Guiseppe, Moleti, Mariacarla, Ferraù, Francesco, Cannavò, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072124/
https://www.ncbi.nlm.nih.gov/pubmed/34942671
http://dx.doi.org/10.1055/a-1540-5009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072124/
https://www.ncbi.nlm.nih.gov/pubmed/34942671
http://dx.doi.org/10.1055/a-1540-5009

Ejemplares similares